| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 02/08/2000 | US6022960 Nucleotide sequence coding a chimeric gonadotropin releasing hormone; for vaccine development |
| 02/08/2000 | US6022872 α- and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 02/08/2000 | US6022861 Ketoheterocyclic inhibitors of factor Xa |
| 02/08/2000 | US6022859 Inhibitors of β-amyloid toxicity |
| 02/08/2000 | US6022855 Novel variants of the naturally-occurring protease inhibitor, alpha1-antitrypsin and derived peptides comprising a sequence of-arg-xaa-xaa-arg-; viricides; bactericides; blocking of endoproteolytic activation of a bacterial toxin |
| 02/08/2000 | US6022523 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| 02/05/2000 | CA2242012A1 Measurement of complement activation by biomaterials by means of complement convertase cleavage of peptide substrates |
| 02/03/2000 | WO2000005263A2 Compounds for use in the treatment of inflammation |
| 02/03/2000 | WO2000005250A1 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 02/03/2000 | WO2000005249A2 Synthetic peptides and methods of use for autoimmune disease therapies |
| 02/03/2000 | WO2000005247A1 Method for crystallizing maleic acid salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline |
| 02/03/2000 | WO2000005246A1 Thioazepinone derivatives, preparation method and intermediates therefor, use as medicines and pharmaceutical compositions containing same |
| 02/03/2000 | WO2000005245A2 Inhibitors of urokinase and blood vessel formation |
| 02/03/2000 | WO2000005208A1 Amino-aldehyde solid support, linker therefor and methods of preparation and use thereof |
| 02/03/2000 | WO2000004914A1 Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof |
| 02/03/2000 | WO2000004868A2 Libraries of polyhydroxamates and their analogs |
| 02/03/2000 | WO1999065922A3 Prenyl transferase inhibitors |
| 02/03/2000 | DE19834308A1 Use of proteases as biocatalysts for production of organic acid amides from carboxylic acid esters |
| 02/03/2000 | CA2338524A1 Inhibitors of urokinase and blood vessel formation |
| 02/03/2000 | CA2337756A1 Libraries of polyhydroxamates and their analogs |
| 02/03/2000 | CA2337688A1 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 02/03/2000 | CA2336238A1 Synthetic peptides and methods of use for autoimmune disease therapies |
| 02/03/2000 | CA2302832A1 Method for crystallizing maleic acid salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline |
| 02/02/2000 | EP0976762A1 Crystallization of Alpha-L-aspartyl-L-phenylalanine methyl ester |
| 02/02/2000 | EP0976761A1 Isolation of crystals of alpha-L-aspartyl-L-phenylalanine methyl ester |
| 02/02/2000 | EP0976760A2 Oligopeptides with fungicidal activity |
| 02/02/2000 | EP0976741A1 Micacocidin derivatives |
| 02/02/2000 | EP0975963A1 Prostate specific antigen substrates |
| 02/02/2000 | EP0975747A1 Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses |
| 02/02/2000 | EP0975662A1 Hepatitis c ns3 protease inhibitors |
| 02/02/2000 | EP0975661A1 The proliferation of cell-inhibiting peptide and its use |
| 02/02/2000 | EP0975659A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/02/2000 | EP0975625A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/02/2000 | EP0975612A1 Protease inhibitors |
| 02/02/2000 | EP0975600A1 Heterocyclic derivatives and their use as antithrombotic agents |
| 02/02/2000 | EP0975353A1 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors |
| 02/02/2000 | EP0863915B1 Acylated enol derivatives of alpha-ketoesters and alpha-ketoamides |
| 02/02/2000 | EP0796271B1 Dipeptide p-amidinobenzylamides with n-terminal sulfonyl or aminosulfonyl radicals |
| 02/02/2000 | EP0777683B1 Antiprotozoal cyclic tetrapeptides |
| 02/02/2000 | EP0751783B1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic use of aminoacetylmercapto derivatives |
| 02/02/2000 | EP0706532B1 Peptides having endothelin antagonictic activity,their preparation and pharmaceutical compositions |
| 02/01/2000 | US6020526 Amide-based cationic lipids |
| 02/01/2000 | US6020460 Conformationally stabilized cell adhesion peptides |
| 02/01/2000 | US6020331 β-sheet mimetics and use thereof as protease inhibitors |
| 02/01/2000 | US6020312 Synthetic antibiotics |
| 02/01/2000 | US6020193 Recombinant C-proteinase and processes, methods and uses thereof |
| 02/01/2000 | CA2105492C Glutathione analogs and paralog panels comprising glutathione mimics |
| 01/27/2000 | WO2000004042A1 Peptide compounds |
| 01/27/2000 | WO2000003743A2 Use of inhibitors of prenyltransferases for inhibiting fungal growth |
| 01/27/2000 | WO2000003722A1 Nocathiacin antibiotics |
| 01/27/2000 | DE19828114A1 Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV Prodrugs unstable inhibitors of dipeptidyl peptidase IV |
| 01/27/2000 | CA2337398A1 Nocathiacin antibiotics |
| 01/27/2000 | CA2335381A1 Use of inhibitors of prenyltransferases for inhibiting fungal growth |
| 01/26/2000 | EP0974272A1 Sweetener composition improved in taste |
| 01/26/2000 | EP0973796A1 Method for preparing and purifying an n-alkylated aspartame derivative |
| 01/26/2000 | EP0973540A1 Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18 |
| 01/26/2000 | EP0973538A1 Modified proteins which bind extracellular matrix components |
| 01/26/2000 | EP0973518A1 Semi-synthetic studies toward didemnin analogues |
| 01/26/2000 | EP0788510B1 Dipeptide derivatives, process for producing them and medicaments containing these compounds |
| 01/26/2000 | CN1242768A Antithrombotic organic nitrates |
| 01/25/2000 | US6018062 17-difluoromethylene-estratrienes |
| 01/25/2000 | US6018037 A recombinant dna coding for a peptide containing leucine instead of the usual 13th amino acid methionine; production of motilin; therapuetic applications |
| 01/25/2000 | US6017928 Retroviral protease inhibiting compounds |
| 01/25/2000 | US6017890 Azole peptidomimetics as thrombin receptor antagonists |
| 01/25/2000 | US6017887 Peptide, peptide analog and amino acid analog protease inhibitors |
| 01/25/2000 | US6017719 Targeting cells from heterogeneous suspension; forming cell complexes linked to antibody bound to surface antigen, separating complexes, mixing antibody with peptide that binds and displaces antibody from antigen, releasing target cell |
| 01/25/2000 | US6017536 Simian immunodeficiency virus peptides with antifusogenic and antiviral activities |
| 01/25/2000 | US6017509 Cyclic hexapeptides not comprised of a disulfide bond covalently linked to a radiolabel e.g. technetium; scintigraphic imaging agents; radiodiagnosis and -therapy; antitumor,-carcinogenic and -diabetic agents; stability |
| 01/20/2000 | WO2000002906A1 Dolastatin 15 derivatives |
| 01/20/2000 | WO2000002904A1 Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives and peptide backbone modified derivatives thereof |
| 01/20/2000 | WO2000002903A1 Cs-1 peptidomimetics, compositions and methods of using the same |
| 01/20/2000 | WO2000002898A1 Processes for coupling amino acids using bis-(trichloromethyl) carbonate |
| 01/20/2000 | WO2000002864A1 Precusors for pna-monomers |
| 01/20/2000 | WO1999059526A3 Protease inhibitors |
| 01/20/2000 | CA2334076A1 Processes for coupling amino acids using bis-(trichloromethyl) carbonate |
| 01/20/2000 | CA2332641A1 Dolastatin 15 derivatives |
| 01/19/2000 | EP0972779A2 Oligonucleotide-polyamide conjugates |
| 01/19/2000 | EP0972564A2 Combinatorial strategies for polymer synthesis |
| 01/19/2000 | EP0971891A1 Thrombin inhibitors |
| 01/19/2000 | EP0897392A4 Isolation and use of sh3 binding peptides |
| 01/19/2000 | EP0728144B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
| 01/19/2000 | CN1242014A Novel heterocyclic amide compounds and medicinal uses thereof |
| 01/19/2000 | CN1242007A Cycloalkyl, lactam lactone and related compounds as 'beta'-amyloid peptide release inhibitors |
| 01/18/2000 | US6015904 Stable reagents for the preparation of radio pharmaceuticals |
| 01/18/2000 | US6015879 Compounds for treatment of nervous system disorders including alzheimer's disease, cognition defects, down's syndrome, parkinson's disease, cerebral hemorrhage with amyloidosis, dementia pugilistica, and head trauma |
| 01/18/2000 | US6015877 Compounds for inhibition of proteolysis |
| 01/18/2000 | US6015812 N-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity |
| 01/18/2000 | US6015791 Serine protease inhibitors-cycloheptane derivatives |
| 01/13/2000 | WO2000001730A1 Peptides based on the sequence of human lactoferrin and their use |
| 01/13/2000 | WO2000001726A1 Compounds with growth hormone releasing properties |
| 01/13/2000 | WO2000001714A1 Efflux pump inhibitors |
| 01/13/2000 | WO2000001690A1 Cinnamic acid derivatives as cell adhesion molecules |
| 01/13/2000 | WO2000001687A1 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 01/13/2000 | WO2000001666A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 01/13/2000 | WO1999052936A3 Arginine peptide analogs useful as fibroblast growth factor antagonists |
| 01/13/2000 | WO1999038501A3 Method of regulating glucose metabolism, and reagents related thereto |
| 01/13/2000 | CA2336315A1 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 01/12/2000 | EP0970113A1 Novel monomer elements for marking peptidic nucleic acids |
| 01/12/2000 | EP0969840A1 Thrombin inhibitors |
| 01/12/2000 | EP0548234B1 Cloning of chicken anaemia dna |